Evogene Ltd. — Regulatory Filings 2018

Feb 15, 2018

_________ false

����� ��"�	2 381
EVOGENE LTD
Corporation no: 512838723	10571
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	15/02/2018
	www.isa.gov.il			www.tase.co.il				Reference:	2018-02-015508	Time of broadcast: 11:46 11:45:36

---

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	Delay the publication of a report	_________	_________

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	UBS report on Schedule 13G filed with the SEC

UBS_13G_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 01/01/2018
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: ofer.haviv@evogene.com   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Masliah Sassi Position of Signatory in the reporting corporation: Director of Legal Affairs & Company Secretary Name of Employer Company:
Address: Gad Feinstein 13 , Rehovot 7612001 Telephone: 08-9311901 Facsimile: 08-9466724 E-mail: sassi.masliah@evogene.com 1